Literature DB >> 1356589

Inhibitory effect of CCK-8 and ceruletide on glutamate-induced rises in intracellular free calcium concentrations in rat neuron cultures.

S Shinohara1, G Katsuura, M Eigyo, H Shintaku, N Ibii, A Matsushita.   

Abstract

To study the mechanism by which cholecystokinin octapeptide (CCK-8) and its potent analogue, ceruletide, prevent glutamate-induced neuronal cell death in rat neuron cultures, we examined the effect of both peptides on glutamate-induced increases in the intracellular free calcium concentrations ([Ca2+]i), which are known to be a crucial trigger of the neurodegeneration induced by glutamate. CCK-8 itself did not alter [Ca2+]i in rat neuron cultures. Glutamate increased [Ca2+]i in neuron cultures rapidly and markedly. CCK-8 and ceruletide significantly suppressed the increases in [Ca2+]i induced by glutamate. The maximum inhibitory effects of CCK-8 and ceruletide at 10(-6) M reached 43 and 46% of the response to glutamate, respectively. Gastrin-I and CCK-4 also significantly attenuated the increases in [Ca2+]i induced by glutamate. The inhibitory effect of CCK-8 was completely blocked by the selective antagonist for CCK-B receptors, (+)L-365,260, but not by (-)L-364,718, which is a selective antagonist for CCK-A receptors. CCK-8 significantly suppressed [Ca2+]i response to kainate and high concentrations of extracellular K+, but not to N-methyl-D-aspartate. With cultured astrocytes, CCK-8 did not inhibit the increment of [Ca2+]i induced by glutamate. These findings clearly demonstrated that CCK-8 and ceruletide inhibit glutamate-induced increases in [Ca2+]i in neuron cultures through CCK-B receptors, suggesting that CCK-8 may participate in the central actions of glutamate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356589     DOI: 10.1016/0006-8993(92)91579-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals.

Authors:  M S Wyeth; N Zhang; C R Houser
Journal:  Neuroscience       Date:  2011-12-03       Impact factor: 3.590

2.  Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke.

Authors:  Alba Simats; Laura Ramiro; Raquel Valls; Helena de Ramón; Paula García-Rodríguez; Cyrille Orset; Laura Artigas; Teresa Sardon; Anna Rosell; Joan Montaner
Journal:  Neurotherapeutics       Date:  2022-02-28       Impact factor: 6.088

3.  CCKB receptor activation reduces glutamate-induced depolarization in slices of rat cerebral cortex.

Authors:  J Harro; P Westerling; L Oreland
Journal:  J Neural Transm Gen Sect       Date:  1993
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.